-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Successful completion of World Congress on Nursing Research and Evidence-Based Practice (Nursing 2019)
Susan E. Mazer
Editorial: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
Jie Huang
Editorial: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation